• Koopmans  MPG, Barton Behravesh  C, Cunningham  AA, Adisasmito  WB, Almuhairi  S, Bilivogui  P, et al.; One Health High-Level Expert Panel. The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention. Lancet Infect Dis. 2024;24:e77481.

  • Peacock  TP, Moncla  L, Dudas  G, VanInsberghe  D, Sukhova  K, Lloyd-Smith  JO, et al. The global H5N1 influenza panzootic in mammals. Nature. 2025;637:30413.

  • Uyeki  TM, Milton  S, Abdul Hamid  C, Reinoso Webb  C, Presley  SM, Shetty  V, et al. Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker. N Engl J Med. 2024;390:20289.

  • Bodewes  R, de Mutsert  G, van der Klis  FR, Ventresca  M, Wilks  S, Smith  DJ, et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol. 2011;18:46976.

  • Gostic  KM, Ambrose  M, Worobey  M, Lloyd-Smith  JO. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science. 2016;354:7226.

  • Eisfeld  AJ, Biswas  A, Guan  L, Gu  C, Maemura  T, Trifkovic  S, et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature. 2024;633:42632.

  • Le Sage  V, Jones  JE, Kormuth  KA, Fitzsimmons  WJ, Nturibi  E, Padovani  GH, et al. Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses. PLoS Pathog. 2021;17:e1009273.

  • Le Sage  V, Rockey  NC, French  AJ, McBride  R, McCarthy  KR, Rigatti  LH, et al. Potential pandemic risk of circulating swine H1N2 influenza viruses. Nat Commun. 2024;15:5025.

  • Mueller Brown  K, Le Sage  V, French  AJ, Jones  JE, Padovani  GH, Avery  AJ, et al. Secondary infection with Streptococcus pneumoniae decreases influenza virus replication and is linked to severe disease. FEMS Microbes. 2022;3:xtac007.

  • Reed  LJ, Muench  H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:4937.

  • Nachbagauer  R, Choi  A, Izikson  R, Cox  MM, Palese  P, Krammer  F. Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans. MBio. 2016;7:e0199615.

  • Camp  JV, Bagci  U, Chu  YK, Squier  B, Fraig  M, Uriarte  SM, et al. Lower respiratory tract infection of the ferret by 2009 H1N1 pandemic influenza A virus triggers biphasic, dystemic, and local recruitment of neutrophils. J Virol. 2015;89:873348.

  • Lakdawala  SS, Jayaraman  A, Halpin  RA, Lamirande  EW, Shih  AR, Stockwell  TB, et al. The soft palate is an important site of adaptation for transmissible influenza viruses. Nature. 2015;526:1225.

  • Lakdawala  SS, Shih  AR, Jayaraman  A, Lamirande  EW, Moore  I, Paskel  M, et al. Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets. Virology. 2013;446:34956.

  • Smith  JH, Nagy  T, Driskell  E, Brooks  P, Tompkins  SM, Tripp  RA. Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol. 2011;85:757281.

  • Vidaña  B, Martínez  J, Martínez-Orellana  P, García Migura  L, Montoya  M, Martorell  J, et al. Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. Vet Res (Faisalabad). 2014;45:85.

  • Kosik  I, Yewdell  JW. Influenza hemagglutinin and neuraminidase: yin-yang proteins coevolving to thwart immunity. Viruses. 2019;11:346.

  • Pica  N, Hai  R, Krammer  F, Wang  TT, Maamary  J, Eggink  D, et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A. 2012;109:25738.

  • Throsby  M, van den Brink  E, Jongeneelen  M, Poon  LL, Alard  P, Cornelissen  L, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One. 2008;3:e3942.

  • Wu  NC, Wilson  IA. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med. 2020;10:a038778.

  • Daulagala  P, Cheng  SMS, Chin  A, Luk  LLH, Leung  K, Wu  JT, et al. Avian influenza A(H5N1) neuraminidase inhibition antibodies in healthy adults after exposure to influenza A(H1N1)pdm09. Emerg Infect Dis. 2024;30:16871.

  • Monto  AS, Kendal  AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973;301:6235.

  • Murphy  BR, Kasel  JA, Chanock  RM. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med. 1972;286:132932.

  • Maier  HE, Nachbagauer  R, Kuan  G, Ng  S, Lopez  R, Sanchez  N, et al. Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza A(H1N1)pdm virus shedding and illness in naturally infected adults. Clin Infect Dis. 2020;70:22907.

  • Sidney  J, Kim  A-R, de Vries  RD, Peters  B, Meade  PS, Krammer  F, et al. Targets of influenza human T cell response are mostly conserved in H5N1. . MBio. 2024.

  • Eisfeld  AJ, Biswas  A, Guan  L, Gu  C, Maemura  T, Trifkovic  S, et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature. 2024;633:42632.

  • Gu  C, Maemura  T, Guan  L, Eisfeld  AJ, Biswas  A, Kiso  M, et al. A human isolate of bovine H5N1 is transmissible and lethal in animal models. Nature. 2024;636:7118.

  • Pulit-Penaloza  JA, Belser  JA, Brock  N, Kieran  TJ, Sun  X, Pappas  C, et al. Transmission of a human isolate of clade 2.3.4.4b A(H5N1) virus in ferrets. Nature. 2024;636:70510.

  • Nuñez  IA, Jang  H, Huang  Y, Kelvin  A, Ross  TM. Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1. Front Vet Sci. 2023;10:1286758.

  • Skarlupka  AL, Zhang  X, Blas-Machado  U, Sumner  SF, Ross  TM. Multi-influenza HA subtype protection of ferrets vaccinated with an N1 COBRA-based neuraminidase. Viruses. 2023;15:184.

  • Uno  N, Ebensen  T, Guzman  CA, Ross  TM. Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses. J Virol. 2024;98:e0035424.

  • Furey  C, Scher  G, Ye  N, Kercher  L, DeBeauchamp  J, Crumpton  JC, et al. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Nat Commun. 2024;15:4350.



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *